Servatus begins dosing in world-first microbiome-focused rheumatoid arthritis trial

Servatus Biopharmaceuticals Ltd director and CEO Wayne Finlayson gives Andrew Scott from Proactive a brief recap on the company which has two platforms,...

Related Keywords

Wayne Finlayson ,Andrew Scott ,Servatus Biopharmaceuticals Ltd ,Engineered Protein ,